Guiding Better Pancreatic Cancer Care: New NCCN recommendations to test all pancreatic cancer patients highlight the value of providers and genetic counselors working together to improve care

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines-) Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic v1.2020 December 4, 2019

Pilarski R . The Role of BRCA Testing in Hereditary Pancreatic and Prostate Cancer Families. DOI: 10.1200/EDBK_238977 American Society of Clinical Oncology Educational Book 39 (May 17, 2019) 79-86. PMID: 31099688

Pishvaian MJ et.al. Outcomes in Patients with Pancreatic Adenocarcinoma with Genetic Mutations in DNA Damage Response Pathways: Results From the Know Your Tumor Program. DOI: 10.1200/PO.19.00115 JCO Precision Oncology - published online October 23, 2019

Lowery MA , et.al. Prospective Evaluation of Germline Alterations in Patients with Exocrine Pancreatic Neoplasms. JNCI 2018; 110(10):1067-1074 PMID:29506128 doi:10.1093/jnci/djy024

Yang X et.al. Cancer Risks Associated with Germline PALB2 Pathogenic Variants: An International Study of 524 Families. JCO DOI: 10.1200/ JCO.19.01907 Journal of Clinical Oncology Published online December 16, 2019. PMID: 31841383

Goggins M , Overbeek KA , Brand R International Cancer of the Pancreas Screening (CAPS) consortium, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium Gut 2020; 69:7-17. doi:10.1136/gutjnl-2019-319352

Underhill ML et.al. Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk. J Cancer Educ, 2019 Nov 7 DOI:10.1007/s13187-019-01623-1 PMID: 31701425